We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 19, 2022

Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Cancer

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial
Clin. Cancer Res 2022 Oct 03;[EPub Ahead of Print], G Basile, M Bandini, EA Gibb, JS Ross, D Raggi, L Marandino, T Costa de Padua, E Crupi, R Colombo, M Colecchia, R Lucianò, L Nocera, M Moschini, A Briganti, F Montorsi, A Necchi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading